These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2521787)

  • 1. Histamine H1 receptors mediate increased blood-retinal barrier permeability in experimental diabetes.
    Enea NA; Hollis TM; Kern JA; Gardner TW
    Arch Ophthalmol; 1989 Feb; 107(2):270-4. PubMed ID: 2521787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihistamines reverse blood-ocular barrier breakdown in experimental diabetes.
    Hollis TM; Gardner TW; Vergis GJ; Kirbo BJ; Butler C; Dull RO; Campos MJ; Enea NA
    J Diabet Complications; 1988; 2(1):47-9. PubMed ID: 2898479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astemizole reduces blood-retinal barrier leakage in experimental diabetes.
    Hollis TM; Sill HW; Butler C; Campos MJ; Gardner TW
    J Diabetes Complications; 1992; 6(4):230-5. PubMed ID: 1482780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic histamine synthesis and aortic albumin accumulation in diabetes: activity-uptake relationships.
    Carroll WJ; Hollis TM
    Exp Mol Pathol; 1985 Jun; 42(3):344-52. PubMed ID: 3996555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperbaric oxygen therapy ameliorates the blood-retinal barrier breakdown in diabetic retinopathy.
    Chang YH; Chen PL; Tai MC; Chen CH; Lu DW; Chen JT
    Clin Exp Ophthalmol; 2006 Aug; 34(6):584-9. PubMed ID: 16925707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
    Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
    Retina; 1995; 15(2):134-40. PubMed ID: 7624601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microscopic quantification of fluorescein distribution in retinas of normal and diabetic rats].
    Proença D; Proença RD; Cunha-Vaz JG
    J Fr Ophtalmol; 1990; 13(10):489-91. PubMed ID: 2081838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of insulin treatment on the blood-retinal barrier in rats with streptozocin-induced diabetes.
    Kernell A; Arnqvist H
    Arch Ophthalmol; 1983 Jun; 101(6):968-70. PubMed ID: 6344848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes.
    Do carmo A; Ramos P; Reis A; Proença R; Cunha-vaz JG
    Exp Eye Res; 1998 Nov; 67(5):569-75. PubMed ID: 9878219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of aminoguanidine on the blood-retinal barrier in streptozocin-induced diabetic rats.
    Cho HK; Kozu H; Peyman GA; Parry GJ; Khoobehi B
    Ophthalmic Surg; 1991 Jan; 22(1):44-7. PubMed ID: 1826545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The protective effect of human umbilical cord mesenchymal stem cells-induced neural stem cells in the vitreous on the blood-retinal barrier in diabetic rats].
    Dong M; Zhang W; Chen S; Wang JM; Duan HT; Kong JH; Wang YX; Bi X; Song J
    Zhonghua Yan Ke Za Zhi; 2017 Jan; 53(1):53-58. PubMed ID: 28162200
    [No Abstract]   [Full Text] [Related]  

  • 12. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
    Antonetti DA; Barber AJ; Khin S; Lieth E; Tarbell JM; Gardner TW
    Diabetes; 1998 Dec; 47(12):1953-9. PubMed ID: 9836530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats.
    Bahgat M; Anis HH; Peyman GA; Farahat HG; Parry GJ; Khoobehi B
    Int Ophthalmol; 1991 Sep; 15(5):335-41. PubMed ID: 1835966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcein fluorophotometry in streptozocin-induced diabetic rats.
    Golshani MR; Khoobehi B; Peyman GA; Aras C
    Ophthalmic Surg; 1994 Aug; 25(8):526-31. PubMed ID: 7970535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy.
    Roy MS; Podgor MJ; Bungay P; Grunberger G; Carl J; Ellis D
    Retina; 1987; 7(3):170-6. PubMed ID: 3423432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic vitreous fluorophotometry in experimental diabetes.
    Jones CW; Cunha-Vaz J; Zweig KO; Stein M
    Arch Ophthalmol; 1979 Oct; 97(10):1941-3. PubMed ID: 485921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of H1 and H2 histamine receptor antagonists on the development of endotoxemia in the conscious, unrestrained rat.
    Brackett DJ; Schaefer CF; Wilson MF
    Circ Shock; 1985; 16(2):141-53. PubMed ID: 2414028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent changes in aortic albumin permeability characteristics in experimental diabetes.
    Hollis TM; Enea NA; Kern JA
    Exp Mol Pathol; 1984 Oct; 41(2):207-17. PubMed ID: 6479292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescein distribution in retinas of normal and diabetic rats.
    Grimes PA
    Exp Eye Res; 1985 Aug; 41(2):227-38. PubMed ID: 4065247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.